搜尋結果
Action. Description: Mechanism of Action: Diprophylline is a theophylline derivative which is used similarly to theophylline as a bronchodilator. Pharmacokinetics: Absorption: Rapidly absorbed from the GI tract. Distribution: Distributed into breast milk. Excretion: Mainly excreted unchanged in the urine.
Dosage/Direction for Use. Venous insufficiency 500 mg FC tab 2 tab daily (1 tab at midday & 1 tab in the evening), at mealtimes. 1,000 mg FC tab 1 tab daily, in the morning, at mealtime. Haemorrhoidal attack 500 mg FC tab 6 tab daily for 4 days & then 4 tab daily for the next 3 days, at mealtimes. 1,000 mg FC tab 3 tab daily for 4 days & then 2 ...
Dosage/Direction for Use. SC Adult & adolescent ≥12 yr Severe eosinophilic asthma 100 mg once every 4 wk. Adult CRSwNP 100 mg once every 4 wk. EGPA 300 mg once every 4 wk. HES 300 mg once every 4 wk. Click to view Nucala detailed prescribing information.
Contents. Per tab Dihydrocodeine bitartrate 5 mg, guaifenesin 50 mg, DL-methylephedrine HCl 17.5 mg, chlorpheniramine maleate 1.5 mg. Per 100 mL syrup Dihydrocodeine bitartrate 50 mg, DL-methylephedrine HCl 131.25 mg, guaifenesin 375 mg, chlorpheniramine maleate 15 mg.
Relief of pain & inflammation in lumbago (muscular & fascial lumbago, spondylosis deformans, discopathy & sprain of lumbar spine), OA, humeroscapular periarthritis, tendinitis/tendovaginitis, peritendinitis, humeral epicondylitis, myalgia & post-traumatic swelling/pain.
Dosage/Direction for Use. Initially 40 mg once daily. Patient who does not achieve serum uric acid <6 mg/dL after 2 wk 80 mg once daily. Severe renal impairment 40 mg once daily. Gout flare prophylaxis Flare prophylaxis w/ NSAID or colchicine is recommended upon initiation for up to 6 mth. Click to view Uxenta detailed prescribing information.
IM Primary vaccination schedule of 2 doses (0.5 mL each): Initial dose followed by 2nd dose 2 mth later. If flexibility in the vaccination schedule is necessary, 2nd dose can be administered between 2 & 6 mth after the 1st dose. Immunodeficient or immunosuppressed individual 2nd dose can be given 1-2 mth after the initial dose.
